Figure 1. NFkB and Nrf2 regulate esophageal barrier function during gastresophageal reflux. This mechanistic model implies that NFkB inhibitor and Nrf2 activator can be potentially used for GERD therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.